EMC8
gene geneOn this page
Also known as FAM158B
Summary
EMC8 (ER membrane protein complex subunit 8, HGNC:7864) is a protein-coding gene on chromosome 16q24.1, encoding ER membrane protein complex subunit 8 (O43402). Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins.
Contributes to membrane insertase activity. Involved in protein insertion into ER membrane by stop-transfer membrane-anchor sequence and tail-anchored membrane protein insertion into ER membrane. Located in Golgi apparatus and endoplasmic reticulum. Part of EMC complex.
Source: NCBI Gene 10328 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_006067
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7864 |
| Approved symbol | EMC8 |
| Name | ER membrane protein complex subunit 8 |
| Location | 16q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FAM158B |
| Ensembl gene | ENSG00000131148 |
| Ensembl biotype | protein_coding |
| OMIM | 604886 |
| Entrez | 10328 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 9 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000253457, ENST00000435200, ENST00000595980, ENST00000596852, ENST00000597291, ENST00000600807, ENST00000870911, ENST00000870912, ENST00000965667, ENST00000965668, ENST00000965669, ENST00000965670, ENST00000965671
RefSeq mRNA: 2 — MANE Select: NM_006067
NM_001142288, NM_006067
CCDS: CCDS10954, CCDS45541
Canonical transcript exons
ENST00000253457 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000695664 | 85788974 | 85789050 |
| ENSE00000945795 | 85781211 | 85781280 |
| ENSE00001880830 | 85799065 | 85799544 |
| ENSE00003474732 | 85778624 | 85779867 |
| ENSE00003546372 | 85780379 | 85780473 |
Expression profiles
Bgee: expression breadth ubiquitous, 283 present calls, max score 98.16.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.8505 / max 119.9877, expressed in 1818 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 158416 | 26.2887 | 1816 |
| 158415 | 2.3417 | 1176 |
| 158417 | 1.1217 | 842 |
| 158413 | 0.7387 | 503 |
| 158414 | 0.3597 | 186 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 98.16 | gold quality |
| secondary oocyte | CL:0000655 | 97.59 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 90.32 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.03 | gold quality |
| granulocyte | CL:0000094 | 89.77 | gold quality |
| stromal cell of endometrium | CL:0002255 | 89.71 | gold quality |
| sperm | CL:0000019 | 89.66 | gold quality |
| left testis | UBERON:0004533 | 89.61 | gold quality |
| colonic mucosa | UBERON:0000317 | 89.59 | gold quality |
| right testis | UBERON:0004534 | 89.09 | gold quality |
| adult organism | UBERON:0007023 | 89.03 | gold quality |
| endothelial cell | CL:0000115 | 88.95 | silver quality |
| gastrocnemius | UBERON:0001388 | 88.91 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 88.63 | gold quality |
| parietal pleura | UBERON:0002400 | 88.60 | gold quality |
| heart right ventricle | UBERON:0002080 | 88.56 | gold quality |
| eye | UBERON:0000970 | 88.51 | gold quality |
| visceral pleura | UBERON:0002401 | 88.49 | gold quality |
| gingival epithelium | UBERON:0001949 | 88.46 | gold quality |
| testis | UBERON:0000473 | 88.44 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.36 | gold quality |
| cardiac ventricle | UBERON:0002082 | 88.29 | gold quality |
| muscle of leg | UBERON:0001383 | 88.13 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 88.08 | gold quality |
| retina | UBERON:0000966 | 88.06 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 88.05 | gold quality |
| amniotic fluid | UBERON:0000173 | 87.98 | gold quality |
| pleura | UBERON:0000977 | 87.90 | gold quality |
| monocyte | CL:0000576 | 87.81 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.34 |
| E-MTAB-6142 | no | 227.27 |
| E-HCAD-13 | no | 3.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
50 targeting EMC8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | emc8 | ENSDARG00000017093 |
| mus_musculus | Emc8 | ENSMUSG00000031819 |
| rattus_norvegicus | Emc8 | ENSRNOG00000017654 |
| drosophila_melanogaster | EMC8-9 | FBGN0034791 |
| caenorhabditis_elegans | F25H2.4 | WBGENE00009118 |
Paralogs (1): EMC9 (ENSG00000100908)
Protein
Protein identifiers
ER membrane protein complex subunit 8 — O43402 (reviewed: O43402)
Alternative names: Neighbor of COX4, Protein FAM158B
All UniProt accessions (3): O43402, M0R1B0, Q53Y03
UniProt curated annotations — full annotation on UniProt →
Function. Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes.
Subunit / interactions. Component of the ER membrane protein complex (EMC). EMC8 and EMC9 are mutually exclusive subunits of the EMC complex.
Subcellular location. Endoplasmic reticulum membrane.
Tissue specificity. Expressed in liver, pancreas, heart, lung, kidney, brain, skeletal muscle, and placenta. Expression levels are highest in pancreas and moderate in heart, skeletal muscle, and placenta.
Similarity. Belongs to the EMC8/EMC9 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O43402-1 | 1 | yes |
| O43402-2 | 2 |
RefSeq proteins (2): NP_001135760, NP_006058* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005366 | EMC8/9 | Family |
| IPR037518 | MPN | Domain |
Pfam: PF03665
UniProt features (24 total): strand 12, helix 7, turn 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
9 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8J0O | ELECTRON MICROSCOPY | 3.32 |
| 7ADO | ELECTRON MICROSCOPY | 3.39 |
| 6WW7 | ELECTRON MICROSCOPY | 3.4 |
| 8EOI | ELECTRON MICROSCOPY | 3.4 |
| 8J0N | ELECTRON MICROSCOPY | 3.47 |
| 7ADP | ELECTRON MICROSCOPY | 3.6 |
| 8S9S | ELECTRON MICROSCOPY | 3.6 |
| 9ZZ6 | ELECTRON MICROSCOPY | 4.16 |
| 9C7V | ELECTRON MICROSCOPY | 6.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43402-F1 | 91.60 | 0.84 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 129 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, SHEPARD_CRASH_AND_BURN_MUTANT_UP, TGACCTY_ERR1_Q2, NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GCM_NF2, GOBP_MEMBRANE_ORGANIZATION, GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION, GOBP_LOCALIZATION_WITHIN_MEMBRANE, DANG_BOUND_BY_MYC, BURTON_ADIPOGENESIS_4, CUI_TCF21_TARGETS_2_UP, GOBP_PROTEIN_INSERTION_INTO_MEMBRANE
GO Biological Process (2): protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050), tail-anchored membrane protein insertion into ER membrane (GO:0071816)
GO Molecular Function (2): protein binding (GO:0005515), membrane insertase activity (GO:0032977)
GO Cellular Component (6): cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), Golgi apparatus (GO:0005794), membrane (GO:0016020), EMC complex (GO:0072546)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein insertion into ER membrane | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| binding | 1 |
| establishment of protein localization to membrane | 1 |
| protein carrier activity | 1 |
| intracellular anatomical structure | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| endoplasmic reticulum membrane | 1 |
| membrane protein complex | 1 |
| endoplasmic reticulum protein-containing complex | 1 |
Protein interactions and networks
STRING
918 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EMC8 | COX4I1 | P13073 | 964 |
| EMC8 | COX4I2 | Q96KJ9 | 949 |
| EMC8 | EMC4 | Q5J8M3 | 823 |
| EMC8 | MMGT1 | Q8N4V1 | 823 |
| EMC8 | EMC3 | Q9P0I2 | 794 |
| EMC8 | EMC1 | Q8N766 | 774 |
| EMC8 | EMC2 | Q15006 | 771 |
| EMC8 | EMC7 | Q9NPA0 | 748 |
| EMC8 | EMC6 | Q9BV81 | 735 |
| EMC8 | EMC10 | Q5UCC4 | 708 |
| EMC8 | CLMB | Q96GX8 | 626 |
| EMC8 | GINS2 | Q9Y248 | 570 |
| EMC8 | DDX46 | Q7L014 | 427 |
| EMC8 | FAM8A1 | Q9UBU6 | 391 |
| EMC8 | BSPRY | Q5W0U4 | 387 |
IntAct
135 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EMC2 | EMC8 | psi-mi:“MI:0915”(physical association) | 0.940 |
| EMC2 | EMC8 | psi-mi:“MI:0914”(association) | 0.940 |
| EMC8 | EMC2 | psi-mi:“MI:0915”(physical association) | 0.940 |
| EMC8 | EMC2 | psi-mi:“MI:0914”(association) | 0.940 |
| EMC7 | EMC8 | psi-mi:“MI:0914”(association) | 0.790 |
| EMC3 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| MMGT1 | EMC8 | psi-mi:“MI:0914”(association) | 0.730 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
BioGRID (305): EMC8 (Two-hybrid), EMC8 (Affinity Capture-RNA), EMC8 (Affinity Capture-RNA), EMC8 (Affinity Capture-MS), UBQLN2 (Affinity Capture-MS), EMC2 (Affinity Capture-MS), EMC3 (Affinity Capture-MS), EMC6 (Affinity Capture-MS), MMGT1 (Affinity Capture-MS), EMC1 (Affinity Capture-MS), EMC7 (Affinity Capture-MS), EMC10 (Affinity Capture-MS), EMC8 (Affinity Capture-MS), EMC8 (Affinity Capture-MS), EMC8 (Affinity Capture-MS)
ESM2 similar proteins: A2AWA9, A2RSQ0, A6QQ21, A7TX81, B1H2N3, B5DGH9, B5KFI0, O43242, O43402, O70378, O88545, P11029, P11497, P14685, P23514, P60228, P60229, Q05AY2, Q07G98, Q0IIL1, Q13085, Q1LUA8, Q28559, Q2KJ46, Q32KL5, Q3T102, Q4R4U1, Q4R518, Q4R6G8, Q5FVL2, Q5R5F8, Q5R8K9, Q5R8N4, Q5REY0, Q5SWU9, Q5ZIA5, Q5ZLA5, Q641X8, Q6DRI1, Q6NUC2
Diamond homologs: O43402, O70378, Q32KL5, Q55FM0, Q5FVL2, Q5U1W7, Q9DB76, Q9W1Y1, Q9Y3B6, Q9FG71
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EMC8 | “form complex” | “Endoplasmic reticulum membrane complex, EMC8 variant” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 117 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| PD-L1(CD274) glycosylation and translocation to plasma membrane | 5 | 31.3× | 6e-05 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | 5 | 20.2× | 3e-04 |
| Maturation of spike protein | 6 | 19.2× | 7e-05 |
| Maturation of DENV proteins | 6 | 15.3× | 2e-04 |
| Regulation of RAS by GAPs | 5 | 11.7× | 2e-03 |
| ER-Phagosome pathway | 5 | 7.8× | 5e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| tail-anchored membrane protein insertion into ER membrane | 8 | 73.4× | 2e-11 |
| autophagosome assembly | 7 | 15.4× | 6e-05 |
| ERAD pathway | 8 | 14.2× | 2e-05 |
| protein N-linked glycosylation | 5 | 12.9× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1013 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:85779864:GTCA:G | acceptor_gain | 1.0000 |
| 16:85779866:CA:C | acceptor_gain | 1.0000 |
| 16:85779868:C:CC | acceptor_gain | 1.0000 |
| 16:85780374:CTCA:C | donor_gain | 1.0000 |
| 16:85780377:A:AC | donor_gain | 1.0000 |
| 16:85780378:C:CG | donor_gain | 1.0000 |
| 16:85780378:CTG:C | donor_gain | 1.0000 |
| 16:85780378:CTGG:C | donor_gain | 1.0000 |
| 16:85781206:CTTA:C | donor_loss | 1.0000 |
| 16:85781207:TTA:T | donor_loss | 1.0000 |
| 16:85781208:TACCA:T | donor_loss | 1.0000 |
| 16:85781209:A:AC | donor_gain | 1.0000 |
| 16:85781210:C:CC | donor_gain | 1.0000 |
| 16:85781210:C:CT | donor_loss | 1.0000 |
| 16:85789046:TCAAT:T | acceptor_gain | 1.0000 |
| 16:85789047:CAAT:C | acceptor_gain | 1.0000 |
| 16:85789047:CAATC:C | acceptor_gain | 1.0000 |
| 16:85789048:AATCT:A | acceptor_loss | 1.0000 |
| 16:85789049:ATCT:A | acceptor_loss | 1.0000 |
| 16:85789050:TCTGA:T | acceptor_loss | 1.0000 |
| 16:85789051:C:CA | acceptor_loss | 1.0000 |
| 16:85789051:C:CC | acceptor_gain | 1.0000 |
| 16:85789052:T:C | acceptor_loss | 1.0000 |
| 16:85799060:CTTA:C | donor_loss | 1.0000 |
| 16:85799061:TTA:T | donor_loss | 1.0000 |
| 16:85799063:ACCAG:A | donor_loss | 1.0000 |
| 16:85799064:C:CT | donor_loss | 1.0000 |
| 16:85779863:AGTCA:A | acceptor_gain | 0.9900 |
| 16:85779865:TCA:T | acceptor_gain | 0.9900 |
| 16:85779866:CAC:C | acceptor_gain | 0.9900 |
AlphaMissense
1392 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:85779744:G:C | N199K | 1.000 |
| 16:85779744:G:T | N199K | 1.000 |
| 16:85779750:C:A | W197C | 1.000 |
| 16:85779750:C:G | W197C | 1.000 |
| 16:85779752:A:G | W197R | 1.000 |
| 16:85779752:A:T | W197R | 1.000 |
| 16:85779772:A:G | L190P | 1.000 |
| 16:85779776:G:C | H189D | 1.000 |
| 16:85779787:T:A | D185V | 1.000 |
| 16:85779788:C:G | D185H | 1.000 |
| 16:85780401:A:G | W151R | 1.000 |
| 16:85780401:A:T | W151R | 1.000 |
| 16:85789005:A:C | Y93D | 1.000 |
| 16:85799075:G:T | A74D | 1.000 |
| 16:85799112:G:C | H62D | 1.000 |
| 16:85799213:C:T | G28E | 1.000 |
| 16:85799214:C:A | G28W | 1.000 |
| 16:85799214:C:G | G28R | 1.000 |
| 16:85799214:C:T | G28R | 1.000 |
| 16:85799257:C:A | K13N | 1.000 |
| 16:85799257:C:G | K13N | 1.000 |
| 16:85779751:C:G | W197S | 0.999 |
| 16:85779774:G:C | H189Q | 0.999 |
| 16:85779774:G:T | H189Q | 0.999 |
| 16:85779781:T:A | D187V | 0.999 |
| 16:85779782:C:A | D187Y | 0.999 |
| 16:85779782:C:G | D187H | 0.999 |
| 16:85779783:G:C | F186L | 0.999 |
| 16:85779783:G:T | F186L | 0.999 |
| 16:85779784:A:G | F186S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000092520 (16:85780079 T>C), RS1000109301 (16:85782806 T>A), RS1000155909 (16:85779323 A>C), RS1000235586 (16:85794967 A>T), RS1000266894 (16:85795095 A>C), RS1000411826 (16:85783654 C>G), RS1000462389 (16:85799606 A>C), RS1000558249 (16:85795853 G>A,C), RS1000589380 (16:85796011 C>T), RS1000590328 (16:85779924 C>T), RS1000668326 (16:85782769 C>T), RS1000767125 (16:85800282 C>T), RS1000786364 (16:85787558 G>A), RS1000831746 (16:85791228 T>C), RS1000834522 (16:85799441 C>A,G,T)
Disease associations
OMIM: gene MIM:604886 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004606_20 | Eosinophil count | 7.000000e-11 |
| GCST004624_2 | Sum eosinophil basophil counts | 9.000000e-11 |
| GCST90002381_100 | Eosinophil count | 6.000000e-13 |
| GCST90002382_404 | Eosinophil percentage of white cells | 7.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004842 | eosinophil count |
| EFO:0005090 | basophil count |
| EFO:0007991 | eosinophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | increases expression, increases methylation | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenate | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| Decitabine | affects expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | affects expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
2 cell lines: 1 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1R5 | Abcam HeLa EMC8 KO | Cancer cell line | Female |
| CVCL_D7GB | Ubigene HEK293T EMC8 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.